John Jones

The EUROclass trial: defining subgroups in common variable immunodeficiency.

Eren, M. Vihinen, M. Vlková, 2008, Blood.

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial

G. Morgan, W. Gregory, M. Drayson, 2019, Leukemia.

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Raghavendra C Kamath, A. T. Adebanjo, Jennifer L. Small, 2020, Lancet.

Sequential minimal residual disease (MRD) monitoring: Results from the UK Myeloma XI trial

G. Morgan, W. Gregory, M. Drayson, 2019, Clinical Lymphoma Myeloma and Leukemia.

Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

G. Morgan, W. Gregory, M. Drayson, 2020, Haematologica.